ADXN Addex Therapeutics Ltd.

Nasdaq addextherapeutics.com


$ 9.70 $ -0.25 (-2.54 %)    

Friday, 24-Oct-2025 15:53:37 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 9.6
$ 9.62
$ 9.02 x 100
$ 10.24 x 2
$ 9.50 - $ 9.98
$ 6.51 - $ 12.05
8,933
na
nm
$ 0.71
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 addex-therapeutics-q2-eps-290-down-from-1061-yoy

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(2.90) per share. This is a 127.37 percent decrease over earning...

 addex-therapeutics-q1-eps-133-up-from-137-yoy-sales-7893k-down-from-26883k-yoy

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.33) per share. This is a 2.92 percent increase over losses of...

 addex-therapeutics-fy-2024-gaap-eps-chf-005-down-from-chf-003-yoy-sales-chf-404102k-down-from-chf-1612m-yoy

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of CHF (0.05) per share. This is a 66.67 percent decrease over losse...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION